Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 7Myelodysplastic Syndromes 5Multiple Myeloma 5Neoplasms, Plasma Cell 4Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Leukemia, Myeloid, Acute 3Anemia, Refractory 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic 1

Interventions

Mycophenolic Acid 8Cyclophosphamide 8fludarabine phosphate 7Cyclosporine 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6Radiotherapy 5Cord Blood Stem Cell Transplantation 5Busulfan 5Antilymphocyte Serum 5Tacrolimus 4Methylprednisolone 4Methotrexate 3Granulocyte Colony-Stimulating Factor 3Whole-Body Irradiation 2Sunitinib 2Sirolimus 2Moxifloxacin 2Melphalan 2Ipilimumab 2Flow Cytometry 2Etoposide 2CTLA-4 Antigen 2Amplified Fragment Length Polymorphism Analysis 2venetoclax 1trametinib 1thymoglobulin 1sargramostim 1ruxolitinib 1regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Arsenic Trioxide × Clear all
NCT00020969 2020-10-05

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

CTI BioPharma

Phase 2 Terminated
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡